Oct 4 (Reuters) - A recently recalled batch of Glucagon Emergency Kits, Eli Lilly and Co’s (LLY.N), opens new tab therapy for diabetic patients in crisis, was manufactured at an Indiana factory cited ...

BOSTON - (February 7, 2018) - A new "smart" glucagon delivery system created by researchers from the Joslin Diabetes Center and Harvard School of Engineering and Applied Sciences may make it possible ...

Baqsimi (glucagon) is a prescription drug that’s used to treat severely low blood sugar levels. The drug comes as nasal powder. It’s usually given as a one-time dose. Baqsimi is used in adults and ...

CHICAGO & DUBLIN--(BUSINESS WIRE)-- Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel formulation technology platforms to develop and commercialize ...

While wholesale costs for glucagon skyrocketed over the past decade, out-of-pocket costs haven't increased by much, researchers reported. The cost of unmixed glucagon increased 192% from 2010 to 2020 ...

Lilly's Zepbound price cuts ranged from $50 to $100, depending on the dosage, for consumers who pay cash via the drugmaker's ...

Low doses of a glucagon-like peptide-1 drug, a class better known for reshaping the weight loss market, are now being tested as tools to dial back biological wear and tear in older animals. Early work ...

The FDA has cleared IND applications for UBT-251 injection, a long-acting triple-targeted glucagon-like peptide-1 (GLP-1)/glucose-dependent insulinotropic polypeptide (GIP)/glucagon receptor agonist ...

Dual glucagon (GCG) and GLP-1 agonist mazdutide is already approved for both type 2 diabetes and obesity in China at doses ...

treat severe hypoglycemia (low blood sugar) in adults and children who have diabetes pause movement of the digestive tract during certain radiology exams in adults GlucaGen belongs to a class of drugs ...